Introduction
Obesity has recently been qualified as a condition that is meanwhile posing a more significant threat to human health than undernutrition or infectious diseases (Kopelman 2000) . Notably, such pathologic overweight is also a component of syndrome X, a group of diseases predicted to prevail in the 21st century (Reaven 2005) .
As an etiological variant distinct from purely metabolic aberrations, a correlation between an adenovirus infection and human obesity was discovered about a decade ago (Dhurandar et al. 1997) . This form of infectobesity (Pasarica & Dhurandar 2007) , as it was also termed, has specifically been linked to human adenovirus 36 (Ad36) given that neutralizing antibodies to this agent were revealed in obese subjects and, moreover, Ad36 was shown to be capable of stimulating preadipocyte differentiation (Vangipuram et al. 2004) . Interestingly, PCR data indicated that the Ad36 E1A gene was expressed in an Ad36-infected murine preadipocyte cell line serving as a model for exploring mechanisms of human obesity (Vangipuram et al. 2004 ). Subsequently, Dhurandhar and coworkers established that, in contrast to measurable Ad36 mRNA levels, the control non-adipogenic adenovirus 2 mRNA was not expressed, thus providing a putative clue as to why among these two closely related adenoviruses only Ad36 seems to possess adipogenic potential in humans (Rathod et al. 2007) . In this context, it should be noted that while the E4 gene product appears to be important for certain adenoviral effects, as 
Conjecture and corollaries
Based on my investigations on the potential role of the insulin-retinoblastoma protein (RB) complex in various human diseases including most recently obesity (Radulescu 2006; Radulescu 2007 ) and, moreover, given the fact that the insulin Bchain and Ad5 E1A protein share the LXCXE RB-binding motif (Radulescu & Wendtner 1992) , the present study addressed the question as to whether the Ad36 E1A protein contains an amino acid sequence related thereto which, if present, would significantly corroborate the involvement I had anticipated for RB (inactivation) in obesity.
Intriguingly, I have now identified an LXCXE motif spanning residues 105-109 of human Ad36 E1A protein, both in its 12S and 13S isoforms (Fig. 1) .
Leu Thr Cys His Glu
Ad5 E1A122-126
Leu Val Cys Gly Glu human insulin B-chain17-21
Leu Arg Cys Tyr Glu human Ad36 E1A 12S/13S protein105-109 This finding suggests that, similar to insulin (Radulescu & Wendtner 1992; Radulescu et al. 1995; Radulescu et al. 2000; Radulescu & Schulze 2002; Radulescu 2006; Radulescu & Kehe, 2007; Radulescu 2007) , the Ad36 E1A protein may bind and thereby inactivate RB which in turn could contribute to the genesis of infectobesity.
If this conjecture was experimentally validated, e.g. by demonstrating significant amounts of Ad36 E1A-RB complexes in (pre)adipocytes vs. control cells, then it may be worthwhile exploring as to whether blocking such Ad36 E1A-RB complex formation, e.g. by means of LXCXE motif-"chelating" MCR peptides (Radulescu et al. 2000; Radulescu & Kehe, 2007) , could attenuate or even reverse this metabolic disorder of presumed infectious origin.
Conversely, the Ad36 E1A-insulin similarity unveiled here lends further support to the notion according to which the insulin-RB complex is likely to be crucially involved not only in the pathophysiology of cancer, but also of (both nonviral and viral forms of) obesity (Radulescu 2006; Radulescu 2007 ).
